(PharmaNewsWire.Com, January 19, 2017 ) According to Publisher, the Pharmaceutical Excipients Market is valued at $6.31 billion in 2015 and is projected to reach $10.24 billion by 2022 growing at a CAGR of 7.16% from 2015 to 2022. This market is mainly driven by the increasing demand for functional excipients from the pharmaceutical industry. Increasing demand of patent cliffs, growing demand of generics, and emergence of recent excipients are some of the key factors contributing the market growth. However, increasing quality compliance and regulatory requirements for excipient manufacturers are some of the restraints hampering the market growth. Also restricted number of the U.S. FDA approved manufacturing sites due to regulatory restrictions may also inhibit the market growth. Additionally, Adoption of modern science and reduced drug toxicity are the major challenges faced by the pharmaceutical Excipients Market. For more information http://www.reportsweb.com/pharmaceutical-excipients-global-market-outlook-2015-2022 . Some of the key players in the market include Associated British Foods Plc, Croda International Plc, Evonik Industries Ag, Roquette, Colorcon, Inc., Huntsman Corporation, Eastman Chemical Company, Archer Daniels Midland Company (Adm), Lubrizol Corporation, Fmc Corporation, Avantor Performance Materials, Inc., The Dow Chemical Company, Ashland, Inc., P&G and Basf Se.
Regions Covered: - North America - US - Canada - Mexico - Europe - Germany - France - Italy - UK - Spain - Rest of Europe - Asia Pacific - Japan - China - India - Australia - New Zealand - Rest of Asia Pacific - Rest of the World - Middle East - Brazil - Argentina - South Africa - Egypt
What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
